LB Pharmaceuticals Inc (LBRX) ROE
- 2026-06-30: ROE -25.78%.
- 2026-03-31: ROE -10.29%.
- 2025-12-31: ROE -8.37%.
- 2025-09-30: ROE -6.06%.
Complete source-backed roe history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -25.78% |
| 2026-03-31 | -10.29% |
| 2025-12-31 | -8.37% |
| 2025-09-30 | -6.06% |
| 2025-06-30 | 28.33% |
| 2025-03-31 | 52.54% |
| 2024-12-31 | 66.74% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -8.37% |
| 2024-12-31 | 66.74% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |